State Street Amends Passive Stake in Catalyst Pharma
Ticker: CPRX · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1369568
| Field | Detail |
|---|---|
| Company | Catalyst Pharmaceuticals, Inc. (CPRX) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**State Street still holds Catalyst Pharma shares, signaling continued institutional interest.**
AI Summary
State Street Corp, a major financial institution, filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Catalyst Pharmaceuticals Inc. common stock as of December 31, 2023. This filing is an amendment, meaning State Street previously reported its stake and is updating that information. For investors, this confirms State Street's continued, significant passive interest in Catalyst Pharmaceuticals, suggesting institutional confidence in the company's long-term prospects.
Why It Matters
This filing shows that a large institutional investor, State Street Corp, continues to hold a significant, passive position in Catalyst Pharmaceuticals, which can be a positive signal for other investors.
Risk Assessment
Risk Level: low — This is a routine amendment by a passive institutional investor and does not indicate any immediate risk or change in company operations.
Analyst Insight
An investor should note that State Street Corp maintains a passive stake in Catalyst Pharmaceuticals, suggesting continued institutional interest. While not a direct buy signal, it indicates a major player sees value in the company. Further research into Catalyst's fundamentals and recent performance would be prudent.
Key Players & Entities
- State Street Corp (company) — the entity filing the SC 13G/A, a large institutional investor
- CATALYST PHARMACEUTICALS, INC. (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing of this statement
- January 25, 2024 (date) — the date the SC 13G/A amendment was filed
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, indicating a change or update to previously reported beneficial ownership.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is State Street Corp, a financial institution based in Boston, MA.
Which company's stock is the subject of this filing?
The subject company whose common stock is being reported is CATALYST PHARMACEUTICALS, INC., a pharmaceutical preparations company based in Coral Gables, FL.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13D-1(B), as indicated by the 'X' in the appropriate box.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding CATALYST PHARMACEUTICALS, INC. (CPRX).